rsp
23.10.2010, 09:22
В Stroke в ближайшем будущем появится Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association ([Ссылки могут видеть только зарегистрированные и активированные пользователи]). Весьма любопытный документ и, надо сказать, уже не так категоричен в отношении каротидного стентирования:
5. CAS is indicated as an alternative to CEA for
symptomatic patients at average or low risk of
complications associated with endovascular intervention
when the diameter of the lumen of the
internal carotid artery is reduced by >70% by
noninvasive imaging or >50% by catheter angiography
(Class I; Level of Evidence B).
7. CAS in the above setting is reasonable when performed
by operators with established periprocedural
morbidity and mortality rates of 4% to 6%,
similar to those observed in trials of CEA and CAS
(Class IIa; Level of Evidence B).
Появилась тенденция в необходимости более ранней реваскуляризации:
4. When CEA is indicated for patients with TIA or
stroke, surgery within 2 weeks is reasonable rather than
delaying surgery if there are no contraindications to early
revascularization (Class IIa; Level of Evidence B).
5. CAS is indicated as an alternative to CEA for
symptomatic patients at average or low risk of
complications associated with endovascular intervention
when the diameter of the lumen of the
internal carotid artery is reduced by >70% by
noninvasive imaging or >50% by catheter angiography
(Class I; Level of Evidence B).
7. CAS in the above setting is reasonable when performed
by operators with established periprocedural
morbidity and mortality rates of 4% to 6%,
similar to those observed in trials of CEA and CAS
(Class IIa; Level of Evidence B).
Появилась тенденция в необходимости более ранней реваскуляризации:
4. When CEA is indicated for patients with TIA or
stroke, surgery within 2 weeks is reasonable rather than
delaying surgery if there are no contraindications to early
revascularization (Class IIa; Level of Evidence B).